Design, synthesis, and antibacterial properties of dual-ligand inhibitors of acetyl-CoA carboxylase

Journal of Medicinal Chemistry

Volumn 57, Issue 21, 2014, Pages 8947-8959

  Silvers, Molly A ^a   Robertson, Gregory T ^b   Taylor, Carol M ^a   Waldrop, Grover L ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; BIOTIN; CARBOXYLASE; CARBOXYLTRANSFERASE; FATTY ACID; HYDROCARBON; LIGASE INHIBITOR; 2-AMINO-N,N-DIBENZYLOXAZOLE-5-CARBOXAMIDE; ANTIINFECTIVE AGENT; ENZYME INHIBITOR; OXAZOLE DERIVATIVE; TRANSFERASE;

ANTIBACTERIAL ACTIVITY; ARTICLE; CATALYSIS; CONTROLLED STUDY; DRUG DESIGN; DRUG SYNTHESIS; FATTY ACID SYNTHESIS; MICROBIOLOGY; NONHUMAN; ANTAGONISTS AND INHIBITORS; MICROBIAL SENSITIVITY TEST; SYNTHESIS;

ACETYL-COA CARBOXYLASE; ANTI-BACTERIAL AGENTS; CARBOXYL AND CARBAMOYL TRANSFERASES; ENZYME INHIBITORS; MICROBIAL SENSITIVITY TESTS; OXAZOLES;

EID: 84923793605     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm501082n     Document Type: Article

References (44)

1. CDC. Antibiotic Resistance Threats in the United States, 2013; U.S. Department of Health and Human Services, Centers for Disease Control and Prevention: Atlanta, GA, 2013; http://www.cdc.gov/drugresistance/threat-report-2013/.
2. Heath, R. J.; Rock, C. O. Fatty acid biosynthesis as a target for novel antibacterials Curr. Opin. Investig. Drugs 2004, 5, 146-153
3. Zhang, Y. M.; White, S. W.; Rock, C. O. Inhibiting bacterial fatty acid synthesis J. Biol. Chem. 2006, 281, 17541-17544
4. Campbell, J. W.; Cronan, J. E., Jr. Bacterial fatty acid biosynthesis: targets for antibacterial drug discovery Annu. Rev. Microbiol. 2001, 55, 305-332
5. Cronan, J. E., Jr.; Waldrop, G. L. Multi-subunit acetyl-CoA carboxylases Prog. Lipid Res. 2002, 41, 407-435
6. Tanabe, T.; Wada, K.; Okazaki, T.; Numa, S. Acetyl-coenzyme-A carboxylase from rat liver. Subunit structure and proteolytic modification Eur. J. Biochem. 1975, 57, 15-24
7. Rock, C. O.; Cronan, J. E. Escherichia coli as a model for the regulation of dissociable (type II) fatty acid biosynthesis Biochim. Biophys. Acta 1996, 1302, 1-16
8. Heath, R. J.; White, S. W.; Rock, C. O. Inhibitors of fatty acid synthesis as antimicrobial chemotherapeutics Appl. Microbiol. Biotechnol. 2002, 58, 695-703
9. Miller, J. R.; Dunham, S.; Mochalkin, I.; Banotai, C.; Bowman, M.; Buist, S.; Dunkle, B.; Hanna, D.; Harwood, H. J.; Huband, M. D.; Karnovsky, A.; Kuhn, M.; Limberakis, C.; Liu, J. Y.; Mehrens, S.; Mueller, W. T.; Narasimhan, L.; Ogden, A.; Ohren, J.; Prasad, J. V.; Shelly, J. A.; Skerlos, L.; Sulavik, M.; Thomas, V. H.; VanderRoest, S.; Wang, L.; Wang, Z.; Whitton, A.; Zhu, T.; Stover, C. K. A class of selective antibacterials derived from a protein kinase inhibitor pharmacophore Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 1737-1742
10. Mochalkin, I.; Miller, J. R.; Narasimhan, L.; Thanabal, V.; Erdman, P.; Cox, P. B.; Prasad, J. V.; Lightle, S.; Huband, M. D.; Stover, C. K. Discovery of antibacterial biotin carboxylase inhibitors by virtual screening and fragment-based approaches ACS Chem. Biol. 2009, 4, 473-483
11. Needham, J.; Kelly, M. T.; Ishige, M.; Andersen, R. J. Andrimid and moiramides A-C, metabolites produced in culture by a marine isolate of the bacterium Pseudomonas fluorescens: Structure elucidation and biosynthesis J. Org. Chem. 1994, 59, 2058-2063
12. Freiberg, C.; Brunner, N. A.; Schiffer, G.; Lampe, T.; Pohlmann, J.; Brands, M.; Raabe, M.; Habich, D.; Ziegelbauer, K. Identification and characterization of the first class of potent bacterial acetyl-CoA carboxylase inhibitors with antibacterial activity J. Biol. Chem. 2004, 279, 26066-26073
13. Pohlmann, J.; Lampe, T.; Shimada, M.; Nell, P. G.; Pernerstorfer, J.; Svenstrup, N.; Brunner, N. A.; Schiffer, G.; Freiberg, C. Pyrrolidinedione derivatives as antibacterial agents with a novel mode of action Bioorg. Med. Chem. Lett. 2005, 15, 1189-1192
14. The activity of carboxyltransferase is measured in the reverse or non-physiological direction where malonyl-CoA and biocytin (a biotin analogue) are the substrates. The formation of the product acetyl-CoA is detected using the coupling enzymes, citrate synthase and malate dehydrogenase: Blanchard, C. Z.; Waldrop, G. L. Overexpression and kinetic characterization of the carboxyltransferase component of acetyl-CoA carboxylase J. Biol. Chem. 1998, 273, 19140-19145
15. Li, S. J.; Cronan, J. E., Jr. Growth rate regulation of Escherichia coli acetyl coenzyme A carboxylase, which catalyzes the first committed step of lipid biosynthesis J. Bacteriol. 1993, 175, 332-340
16. Silver, L. L. Multi-targeting by monotherapeutic antibacterials Nat. Rev. Drug Discovery 2007, 6, 41-55
17. Pokrovskaya, V.; Baasov, T. Dual-acting hybrid antibiotics: a promising strategy to combat bacterial resistance Expert Opin. Drug Discovery 2010, 5, 883-902
18. OConnell, K. M.; Hodgkinson, J. T.; Sore, H. F.; Welch, M.; Salmond, G. P.; Spring, D. R. Combating multidrug-resistant bacteria: Current strategies for the discovery of novel antibacterials Angew. Chem., Int. Ed. 2013, 10706-10733
19. East, S. P.; Silver, L. L. Multitarget ligands in antibacterial research: progress and opportunities Expert Opin. Drug Discovery 2013, 8, 143-156
20. Broussard, T. C.; Price, A. E.; Laborde, S. M.; Waldrop, G. L. Complex formation and regulation of Escherichia coli acetyl-CoA carboxylase Biochemistry 2013, 52, 3346-3357
21. Li, H. Q.; Yan, T.; Yang, Y.; Shi, L.; Zhou, C. F.; Zhu, H. L. Synthesis and structure-activity relationships of N -benzyl- N -(X-2-hydroxybenzyl)- N -phenylureas and thioureas as antitumor agents Bioorg. Med. Chem. 2010, 18, 305-313
22. McWhorter, W.; Fredenhagen, A.; Nakanishi, K.; Komura, H. Stereocontrolled synthesis of andrimid and a structural requirement for the activity J. Chem. Soc., Chem. Commun. 1989, 299-301
23. Rama Rao, A. V.; Singh, A. K.; Varaprasad, C. V. N. S. A convenient diastereoselective total synthesis of andrimid Tetrahedron Lett. 1991, 32, 4393-4396
24. Davies, S. G.; Dixon, D. J. Asymmetric syntheses of moiramide B and andrimid J. Chem. Soc., Perkin Trans. 1 1998, 2635-2643
25. Fredenhagen, A.; Tamura, S. Y.; Kenny, P. T. M.; Komura, H.; Naya, Y.; Nakanishi, K.; Niegyama, K.; Sugiura, M.; Kita, H. Andrimid, a new peptide antibiotic produced by an intracellular bacterial symbiont isolated from a brown planthopper J. Am. Chem. Soc. 1987, 109, 4409-4411
26. Midgley, G.; Thomas, C. B. Selectivity of radical formation in the reaction of carbonyl-compounds with manganese (III) acetate J. Chem. Soc., Perkin Trans. 2 1987, 1103-1108
27. Bailey, P. D.; Morgan, K. M.; Smith, D. I.; Vernon, J. M. Spiro cyclisations of N- acyliminium ions involving an aromatic π-nucleophile Tetrahedron Lett. 2003, 59, 3369-3378
28. Robin, S.; Zhu, J.; Galons, H.; Pham-Huy, C.; Claude, J. R.; Tomas, A.; Viossat, B. A convenient asymmetric synthesis of thalidomide Tetrahedron: Asymmetry 1995, 6, 1249-1252
29. Aron, Z. D.; Overman, L. E. Total synthesis and properties of the crambescidin core zwitterionic acid and crambescidin 359 J. Am. Chem. Soc. 2005, 127, 3380-3390
30. Jobron, L.; Hummel, G. Solid-phase synthesis of new S-glycoamino acid building blocks Org. Lett. 2000, 2, 2265-2267
31. Zhang, Q.; Wu, Y.; Wang, L.; Hu, B.; Li, P.; Liu, F. Effect of hapten structures on specific and sensitive enzyme-linked immunosorbent assays for N -methylcarbamate insecticide metolcarb Anal. Chim. Acta 2008, 625, 87-94
32. Bennett, B. D.; Kimball, E. H.; Gao, M.; Osterhout, R.; Van Dien, S. J.; Rabinowitz, J. D. Absolute metabolite concentrations and implied enzyme active site occupancy in Escherichia coli Nat. Chem. Biol. 2009, 5, 593-599
33. Freiberg, C.; Pohlmann, J.; Nell, P. G.; Endermann, R.; Schuhmacher, J.; Newton, B.; Otteneder, M.; Lampe, T.; Habich, D.; Ziegelbauer, K. Novel bacterial acetyl coenzyme A carboxylase inhibitors with antibiotic efficacy in vivo Antimicrob. Agents Chemother. 2006, 50, 2707-2712
34. Robertson, G. T.; Bonventre, E. J.; Doyle, T. B.; Du, Q.; Duncan, L.; Morris, T. W.; Roche, E. D.; Yan, D.; Lynch, A. S. In vitro evaluation of CBR-2092, a novel rifamycin-quinolone hybrid antibiotic: microbiology profiling studies with staphylococci and streptococci Antimicrob. Agents Chemother. 2008, 52, 2324-2334
35. Aeschlimann, J. R.; Dresser, L. D.; Kaatz, G. W.; Rybak, M. J. Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus Antimicrob. Agents Chemother. 1999, 43, 335-340
36. Viljanen, P.; Vaara, M. Susceptibility of Gram-negative bacteria to polymyxin B nonapeptide Antimicrob. Agents Chemother. 1984, 25, 701-705
37. Tsubery, H.; Ofek, I.; Cohen, S.; Eisenstein, M.; Fridkin, M. Modulation of the hydrophobic domain of polymyxin B nonapeptide: effect on outer-membrane permeabilization and lipopolysaccharide neutralization Mol. Pharmacol. 2002, 62, 1036-1042
38. Zavascki, A. P.; Goldani, L. Z.; Li, J.; Nation, R. L. Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review J. Antimicrob. Chemother. 2007, 60, 1206-1215
39. Velkov, T.; Roberts, K. D.; Nation, R. L.; Wang, J.; Thompson, P. E.; Li, J. Teaching old polymyxins new tricks: new-generation lipopeptides targeting Gram-negative superbugs ACS Chem. Biol. 2014, 9, 1172-1177
40. Zhao, X.; Drlica, K. Restricting the selection of antibiotic-resistant mutant bacteria: measurement and potential use of the mutant selection window J. Infect. Dis. 2002, 185, 561-565
41. Drlica, K. The mutant selection window and antimicrobial resistance J. Antimicrob. Chemother. 2003, 52, 11-17
42. Brylinski, M.; Waldrop, G. L. Computational redesign of bacterial biotin carboxylase inhibitors using structure-based virtual screening of combinatorial libraries Molecules 2014, 19, 4021-4045
43. Cleland, W. W. Statistical analysis of enzyme kinetic data Methods Enzymol. 1979, 63, 103-138
44. Clinical and Laboratory Standards Institute. Methods fordilution antimicrobial susceptibility tests for bacteria that growaerobically, approved standard, 7 th ed.; Clinical and Laboratory Standards Institute: Wayne, PA, 2006; CLSI document M7-A7, Vol. 26, no. 2.